Proteosome-Lipopeptide Vaccines: Enhancement of Immunogenicity for Malaria CS Peptides

作者：George H. Lowell, W. Ripley Ballou, Lynette F. Smith, Robert A. Wirtz, Wendell D. Zollinger, Wayne T. Hockmeyer · 发表于：Science · 年份：1988 · DOI：10.1126/science.2452484 · 被引用次数：114 · 研究领域：vaccines and immunoinformatics approaches、Malaria Research and Control、RNA and protein synthesis mechanisms

Proteosomes are hydrophobic, membranous, multimolecular preparations of meningococcal outer membrane proteins that are also B cell mitogens. These characteristics suggested that proteosomes may serve as carrier proteins and adjuvants to enhance peptide immunogenicity. Although high titers of malaria circumsporozoite (CS) antibodies protect against malaria, vaccines thus far tested in humans have been insufficiently immunogenic to be clinically useful. Here it is shown that synthetic CS peptides hydrophobically complexed to proteosomes by way of lauroyl-cysteine become highly immunogenic in mice without other adjuvants. The high titers of antibodies produced and the safety of proteosomes in humans suggest that this novel system is widely applicable for the development of peptide vaccines to protect against many diseases.